Literature DB >> 28087938

The Role and Function of Fcγ Receptors on Myeloid Cells.

Stylianos Bournazos, Taia T Wang, Jeffrey V Ravetch.   

Abstract

A key determinant for the survival of organisms is their capacity to recognize and respond efficiently to foreign antigens. This is largely accomplished by the orchestrated activity of the innate and adaptive branches of the immune system. Antibodies are specifically generated in response to foreign antigens, facilitating thereby the specific recognition of antigens of almost infinite diversity. Receptors specific for the Fc domain of antibodies, Fc receptors, are expressed on the surface of the various myeloid leukocyte populations and mediate the binding and recognition of antibodies by innate leukocytes. By directly linking the innate and the adaptive components of immunity, Fc receptors play a central role in host defense and the maintenance of tissue homeostasis through the induction of diverse proinflammatory, anti-inflammatory, and immunomodulatory processes that are initiated upon engagement by the Fc domain. In this chapter, we discuss the mechanisms that regulate Fc domain binding to the various types of Fc receptors and provide an overview of the astonishing diversity of effector functions that are mediated through Fc-FcR interactions on myeloid cells. Lastly, we discuss the impact of FcR-mediated interactions in the context of IgG-mediated inflammation, autoimmunity, susceptibility to infection, and responsiveness to antibody-based therapeutics.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28087938      PMCID: PMC5240797          DOI: 10.1128/microbiolspec.MCHD-0045-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  216 in total

1.  Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.

Authors:  P Sondermann; J Kaiser; U Jacob
Journal:  J Mol Biol       Date:  2001-06-08       Impact factor: 5.469

2.  FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.

Authors:  Hajime Kono; Chieko Kyogoku; Takeshi Suzuki; Naoyuki Tsuchiya; Hiroaki Honda; Kazuhiko Yamamoto; Katsushi Tokunaga; Zen-Ichiro Honda
Journal:  Hum Mol Genet       Date:  2005-08-22       Impact factor: 6.150

3.  Divergent immunoglobulin g subclass activity through selective Fc receptor binding.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

4.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

5.  Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene.

Authors:  Guillaume Cartron; Laurent Dacheux; Gilles Salles; Philippe Solal-Celigny; Pierre Bardos; Philippe Colombat; Hervé Watier
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 6.  Recognition of immunoglobulins by Fcgamma receptors.

Authors:  Sergei Radaev; Peter Sun
Journal:  Mol Immunol       Date:  2002-05       Impact factor: 4.407

7.  Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro.

Authors:  Shanley Blackley; Zhihua Kou; Huiyuan Chen; Matthew Quinn; Robert C Rose; Jacob J Schlesinger; Myra Coppage; Xia Jin
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 8.  The coordination of signaling during Fc receptor-mediated phagocytosis.

Authors:  Joel A Swanson; Adam D Hoppe
Journal:  J Leukoc Biol       Date:  2004-10-05       Impact factor: 4.962

9.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.

Authors:  D G Brooks; W Q Qiu; A D Luster; J V Ravetch
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  41 in total

1.  Capsular glycan recognition provides antibody-mediated immunity against tuberculosis.

Authors:  Tingting Chen; Caroline Blanc; Yanyan Liu; Elise Ishida; Sarah Singer; Jiayong Xu; Maju Joe; Elizabeth R Jenny-Avital; John Chan; Todd L Lowary; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

2.  Cyclophosphamide Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression.

Authors:  Ali Roghanian; Guangan Hu; Christopher Fraser; Maneesh Singh; Russell B Foxall; Matthew J Meyer; Emma Lees; Heather Huet; Martin J Glennie; Stephen A Beers; Sean H Lim; Margaret Ashton-Key; Stephen M Thirdborough; Mark S Cragg; Jianzhu Chen
Journal:  Cancer Immunol Res       Date:  2019-08-26       Impact factor: 11.151

3.  CD31 Acts as a Checkpoint Molecule and Is Modulated by FcγR-Mediated Signaling in Monocytes.

Authors:  Giovanna Merchand-Reyes; Frank H Robledo-Avila; Nathaniel J Buteyn; Shalini Gautam; Ramasamy Santhanam; Kavin Fatehchand; Xiaokui Mo; Santiago Partida-Sanchez; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2019-11-15       Impact factor: 5.422

Review 4.  Beyond binding: antibody effector functions in infectious diseases.

Authors:  Lenette L Lu; Todd J Suscovich; Sarah M Fortune; Galit Alter
Journal:  Nat Rev Immunol       Date:  2017-10-24       Impact factor: 53.106

5.  Recruitment of activated neutrophils correlates with disease severity in adult Crohn's disease.

Authors:  A Therrien; L Chapuy; M Bsat; M Rubio; G Bernard; E Arslanian; K Orlicka; A Weber; B-P Panzini; J Dorais; E-J Bernard; G Soucy; M Bouin; M Sarfati
Journal:  Clin Exp Immunol       Date:  2018-11-28       Impact factor: 4.330

Review 6.  Intersection of FcγRIIB, the microbiome, and checkpoint inhibitors in antitumor immunity.

Authors:  Kirsten M Baecher; Mandy L Ford
Journal:  Cancer Immunol Immunother       Date:  2021-07-09       Impact factor: 6.968

Review 7.  Serine/threonine phosphatases in osteoclastogenesis and bone resorption.

Authors:  Ismael Y Karkache; Jeyaram R Damodaran; David H H Molstad; Elizabeth W Bradley
Journal:  Gene       Date:  2020-12-16       Impact factor: 3.688

8.  An integrative network analysis framework for identifying molecular functions in complex disorders examining major depressive disorder as a test case.

Authors:  Anup Mammen Oommen; Stephen Cunningham; Páraic S O'Súilleabháin; Brian M Hughes; Lokesh Joshi
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

Review 9.  Agonist antibody discovery: Experimental, computational, and rational engineering approaches.

Authors:  John S Schardt; Harkamal S Jhajj; Ryen L O'Meara; Timon S Lwo; Matthew D Smith; Peter M Tessier
Journal:  Drug Discov Today       Date:  2021-09-24       Impact factor: 7.851

10.  Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids.

Authors:  Erkko Ylösmäki; Jacopo Chiaro; Firas Hamdan; Yvonne Giannoula; Maeve Long; Manlio Fusciello; Sara Feola; Beatriz Martins; Michaela Feodoroff; Gabriella Antignani; Salvatore Russo; Otto Kari; Moon Lee; Petrus Järvinen; Harry Nisen; Anna Kreutzman; Jeanette Leusen; Satu Mustjoki; Thomas G McWilliams; Mikaela Grönholm; Vincenzo Cerullo
Journal:  J Immunother Cancer       Date:  2021-08       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.